Nanocarriers as an emerging platform for cancer therapy | Nature Nanotechnology | 2007 | 6.5K |
Cancer nanomedicine: progress, challenges and opportunities | Nature Reviews Cancer | 2017 | 3K |
Factors affecting the clearance and biodistribution of polymeric nanoparticles | Molecular Pharmaceutics | 2008 | 2.6K |
Impact of nanotechnology on drug delivery | ACS Nano | 2009 | 2.3K |
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators | Nature Reviews Immunology | 2008 | 2.1K |
Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology | Advanced Drug Delivery Reviews | 2014 | 1.8K |
Nanoparticles in medicine: therapeutic applications and developments | Clinical Pharmacology and Therapeutics | 2008 | 1.8K |
Pro-resolving lipid mediators are leads for resolution physiology | Nature | 2014 | 1.7K |
Resolution of inflammation: the beginning programs the end | Nature Immunology | 2005 | 1.7K |
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo | Proceedings of the National Academy of Sciences of the United States of America | 2006 | 1.4K |
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release | Chemical Reviews | 2016 | 1.4K |
Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals | Journal of Experimental Medicine | 2002 | 1.3K |
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation | Chemical Society Reviews | 2012 | 1.3K |
Nanoparticle delivery of cancer drugs | Annual Review of Medicine | 2012 | 1.2K |
Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery | Biomaterials | 2007 | 1.1K |
Cellular uptake of nanoparticles: journey inside the cell | Chemical Society Reviews | 2017 | 1K |
Progress and challenges towards targeted delivery of cancer therapeutics | Nature Communications | 2018 | 976 |
Consensus guidelines for the management of postoperative nausea and vomiting | Anesthesia and Analgesia | 2014 | 930 |
Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing | Journal of Experimental Medicine | 2000 | 910 |
Resolvin E1 and protectin D1 activate inflammation-resolution programmes | Nature | 2007 | 904 |
Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile | Science Translational Medicine | 2012 | 866 |
Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer | Nano Letters | 2007 | 830 |
Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord | Journal of Neuroscience | 2008 | 810 |
Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles | Proceedings of the National Academy of Sciences of the United States of America | 2008 | 805 |
Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells | Cancer Research | 2004 | 788 |